TIS6463

TIS6463 · Tisento Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TIS6463, covering 2026-03-12 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM) [Phase 2]